Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

– German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group, DGCIN; Atzpodien, Jens; Schmitt, E.; Gertenbach, Ulrich; Fornara, Paolo; Heynemann, H.; Maskow, Arndt; Ecke, M; Wöltjen, H.-H.; Jentsch, Holger; F. Wieland, Wolf; Wandert, T; Reitz, Martina

doi:10.1038/sj.bjc.6602443

Public

Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

Published in British Journal of Cancer • Mar 1, 2005

Authors:

DGCIN – German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group

Jens Atzpodien

E. Schmitt

Abstract

We conducted a prospectively randomised clinical trial to investigate the role of adjuvant outpatient immunochemotherapy administered postoperatively in high-risk patients with renal cell carcinoma. In total, 203 renal carcinoma patients' status post radical tumour nephrectomy were stratified into t...

Subject

Medicine

Chemoimmunotherapy

Renal cell carcinoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!